Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma

C. Brightling (Leicester (Leicestershire), United Kingdom), M. Gaga (Athens, Greece), H. Inoue (Kagoshima, Japan), J. Li (Guangzhou, China), J. Maspero (Buenos Aries, Argentina), S. Wenzel (Pittsburg, United States of America), S. Maitra (Hyderabad, India), D. Lawrence (Basel, Switzerland), F. Brockhaus (Basel, Sweden), T. Lehmann (Basel, Switzerland), C. Brindicci (Basel, Switzerland), B. Knorr (East Hanover, United States of America), E. Bleecker (Tucson, United States of America)

Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Session: ALERT: Asthma in adults and children
Session type: Clinical trials session
Number: 4614

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Brightling (Leicester (Leicestershire), United Kingdom), M. Gaga (Athens, Greece), H. Inoue (Kagoshima, Japan), J. Li (Guangzhou, China), J. Maspero (Buenos Aries, Argentina), S. Wenzel (Pittsburg, United States of America), S. Maitra (Hyderabad, India), D. Lawrence (Basel, Switzerland), F. Brockhaus (Basel, Sweden), T. Lehmann (Basel, Switzerland), C. Brindicci (Basel, Switzerland), B. Knorr (East Hanover, United States of America), E. Bleecker (Tucson, United States of America). Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma. 4614

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: